Study selection criteria. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

PRISMA flow chart. حسب Filip Stanicic (17808254)

"…CAPS improvement was persistent for CPT and PE in long-term follow up (mean duration 6.2 years).</p><p>MDMA-AT demonstrated significant improvement in BDI-II score compared to PT (19.7-point vs. 10.8-point decrease, respectively; p = 0.003). …"

Data for the G7 countries in 2022. حسب Luis Alberiko Gil-Alana (14659817)

"…The results indicate that only France displays a significant negative trend and thus a continuous decrease in the level of alcohol consumption. …"

Time series plots: Alcohol consumption. حسب Luis Alberiko Gil-Alana (14659817)

"…The results indicate that only France displays a significant negative trend and thus a continuous decrease in the level of alcohol consumption. …"

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. حسب Farayi Kaseke (19560197)

Flowchart of patient selection in this study. حسب Kazuyoshi Ohkawa (836847)

"…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …"

S1 Data - حسب Kazuyoshi Ohkawa (836847)

"…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …"

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study flow chart. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

"…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …"

Flow Chart of Study Participant Selection. حسب Zhi Jin (3742471)

"…</p><p>Results</p><p>Among 1,360 participants with T2DM, the mean sleep duration was 6.45 ± 1.95 hours. During follow-up, 237 (17.43%) participants reported new-onset CVD. …"

Reproducibility of response time and brain measures. حسب Jan Willem Koten (17743224)

Effect of corrections on connectivity maps. حسب Jan Willem Koten (17743224)

Passive sensing data. حسب Thierry Jean (20691795)

"…Results also showed that metrics that do not account for imbalance (mean absolute error, accuracy) systematically overestimated performance, XGBoost models performed on par with or better than LSTM models, and a significant yet very small decrease in performance was observed as the forecast horizon expanded. …"

Surveys. حسب Thierry Jean (20691795)

"…Results also showed that metrics that do not account for imbalance (mean absolute error, accuracy) systematically overestimated performance, XGBoost models performed on par with or better than LSTM models, and a significant yet very small decrease in performance was observed as the forecast horizon expanded. …"

Characteristics of the included studies. حسب Xin Liu (43569)

"…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …"

Summary of results. حسب Xin Liu (43569)

"…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …"

Bias risk assessments for each RCT study. حسب Xin Liu (43569)

"…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …"

The flow chart of studies selecting. حسب Xin Liu (43569)

"…The combined findings showed that high-dose TXA was associated with a significant reduction in intraoperative blood loss [weighted mean difference (WMD) =  -215.48, 95% confidence interval (CI) (-367.58, -63.37), P <  0.001], as well as a decreased likelihood of transfusion [risk ratio (RR) =  0.40, 95% CI (0.30, 0.53), P <  0.001]. …"